Project Grant K23HL179456
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $771,750 to the Albert Einstein College of Medicine to conduct a cluster randomized controlled trial called "PRAGMATIC-S". The project aims to create an innovative interface between primary care and school-based programs to optimize the delivery of guideline-based asthma care to urban children with persistent or uncontrolled asthma. The award period runs...
- This Project Grant award, provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), aims to support a mentored implementation science research program focused on improving asthma care and outcomes for children from marginalized communities. The $120,363 award, effective August 18, 2025, will fund Dr. Michelle Eakin's efforts to expand her mentoring program in patient-oriented implementation science. The project will leverage ongoing data collection...
- This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) is providing $731,130 to the Children's Hospital Medical Center to conduct a study titled "Improving Medication Adherence Using an Adaptive mHealth Intervention in Adolescents with Asthma". The study aims to evaluate the effectiveness of a stepped-care mHealth intervention for improving adherence to daily inhaled corticosteroids in adolescents with asthma. The...
- The Project Grant award of $673,581 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports a research project by Ochin, Inc. to assess disparities in asthma care between Latino and non-Hispanic white adults. The project aims to leverage a comprehensive dataset linking electronic health records to community-level social determinants of health data to evaluate factors underlying asthma care utilization disparities. The award runs from March 1, 2025...
- This Project Grant award from the National Heart Lung and Blood Institute, under the Cardiovascular Diseases Research program (CFDA 93.837), is providing $259,752 to the Icahn School of Medicine at Mount Sinai to develop and pilot test an integrated intervention for depression and asthma self-management in older adults. The key products/services being delivered include: Developing a 10-12 session integrated program that combines asthma self-management support (SAMBA) with cognitive behavioral...
- This Project Grant award, totaling $169,444, was provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to develop and pilot test a stress management intervention for Black adults with hypertension. The project will work with patients receiving care from federally-qualified health centers to iteratively design an intervention that addresses patient preferences and aims to promote cardiovascular health. Key outcomes to be examined include...
- This $186,896 Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will fund a study by the Regents of the University of California, San Francisco (UCSF) to examine the impact of adverse childhood experiences (ACEs) screening and behavioral-social support on asthma and chronic obstructive pulmonary disease (COPD) health outcomes. The study aims to leverage data from LADHS' implementation of ACEs screening to 1) analyze the...
- This Project Grant award of $807,067.00 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will support a study to pioneer the quantitative documentation of human respiratory kinematic profiles. The study aims to address a critical gap in contemporary physiological monitoring - the inability to quantify labored breathing, which contains vital prognostic information not captured by conventional monitoring. Building on a recent innovation called ARK...
- The Children's Hospital of Philadelphia (CHOP) received a $135,000 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) on July 16, 2025. The project aims to investigate how clinical, genetic, and social factors interact with short-term ambient air pollution (AAP) exposure to influence asthma exacerbations in pediatric patients. The research will also examine how these variables shape long-term lung function attainment in...
- The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $189,000 Project Grant under CFDA #93.837 Cardiovascular Diseases Research program to the University of Colorado-Denver. The 2-year grant, with a period of performance from September 15, 2025 to August 31, 2027, will support research to investigate the role of outdoor air pollution and environmental allergens in driving treatment response in children with acute asthma...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $187,798 to the University of Rochester to design and pilot a community health worker (CHW) model for improving self-management and outcomes for children with persistent asthma in Rochester, NY. The project aims to use implementation science frameworks to co-design a sustainable, context-appropriate CHW model with community partners, and then evaluate the feasibility, acceptability, and preliminary clinical effectiveness of the model through a single-arm pilot intervention study. The long-term objective is to reduce health disparities in childhood asthma by implementing effective, community-engaged models of asthma care. The award period runs from Sep 1, 2025 to Jul 31, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $187.8k | 8/29/25 |